5 research outputs found

    Analysis of purified MSP-1-BBM protein by SDS-PAGE and Western blotting.

    No full text
    <p>A. Coomassie-stained gel of purified MSP-1-BBM protein produced in <i>T. thermophila</i>. Lane 1. Molecular weight markers. Lane 2. 0.5 µg purified MSP-1-BBM protein. B. Western blot of MSP-1-BBM protein and MSP-1 hybrid probed with with mAb 12.2, (specific for repeat sequences present in the K1 serotype of MSP-1 Block 2). Lane 1. Molecular weight markers. Lane 2. 0.5 µg of <i>Tetrahymena</i>-derived MSP-1-BBM protein. Lane 3. Negative control. Lane 4. 0.5 µg MSP-1 Block 2 hybrid protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Galamo1" target="_blank">[30]</a> (positive control).</p

    Indirect immunofluorescence assay (IFA) of sera from MSP-1-BBM immunized mice against three strains of <i>P. falciparum</i>.

    No full text
    <p>A. Representative micrograph of IFA assay with sera from MSP-1-BBM immunized mice. DAPI staining of parasite nuclei is shown in blue and fluorescence from the FITC-conjugated secondary antibody is shown in green. B. IFA titers of sera from mice immunized with MSP-1-BBM protein. Sera were tested by IFA against the 3D7 (K1 serotype), MAD20 and RO33 strains of <i>P. falciparum</i>, as described in materials and methods. IFA endpoint data is shown on a log<sub>10</sub> scale on the Y axis. Each symbol represents the serum reactivity for an individual animal, with the geometric mean of Ab reactivity against each parasite strain indicated by the solid line. C. Western blot of MSP-1 Block 2 hybrid and MSP1<sub>19</sub> proteins probed with pooled serum from mice immunized with MSP-1-BBM protein. Lane 1: Molecular weight markers, Lane 2: MSP-1 block 2 hybrid protein, Lane 3: MSP1<sub>19</sub>-GST fusion protein.</p

    Immunogenicity in mice of recombinant MSP-1-BBM protein from <i>T. thermophila</i>[49].

    No full text
    <p>A group of five MF1 mice were immunized s.c. three times, at 2 week intervals with MSP-1-BBM protein formulated in CoVaccine HT as described. Twelve days after the last immunization (d40), serum samples from each animal were tested by ELISA for antibody responses against the MSP-1 Block 2 hybrid protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Cowan1" target="_blank">[31]</a> K1-type Block 2 protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Cavanagh2" target="_blank">[54]</a>, MAD20-type Block 2 protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Cavanagh2" target="_blank">[54]</a>, RO33-type Block 2 protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Cavanagh2" target="_blank">[54]</a> and MSP-1<sub>19</sub> protein <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087198#pone.0087198-Burghaus1" target="_blank">[53]</a>. Titers were calculated as outlined in materials and methods and expressed as arbitrary units (AU). Data is shown on a natural logarithmic scale as dotplots of serum reactivity for individual animals with the median level of Ab reactivity indicated by the solid horizontal line.</p

    Epitope mapping of sera from MSP-1-BBM immunized mice by recognition of peptide epitopes within the MSP-1 Block 2 region of the MSP-1-BBM construct.

    No full text
    <p>A series of 133-terminally biotinylated dodecapeptides, representing the sequence diversity of all three Block 2 serotypes were used in ELISA to map the antibody specificities present in the sera of immunized animals. Reactivity with individual peptides is shown as shaded boxes, with the depth of shading of each box representing the strength of reactivity of a 1∶500 dilution of sera with each peptide. The sequences and Block 2 serotype (K1, MAD20 and RO33) of each peptide are indicated down the right hand side of the diagram.</p
    corecore